alan p. venook, md, discusses which molecular tests to order for a newly diagnosed crc patient
Published 7 years ago • 44 plays • Length 1:17
Download video MP4
Download video MP3
Similar videos
-
1:32
philip philip, md, on which molecular tests to order for a newly diagnosed crc patient
-
1:41
alan p. venook, md, explains how the 80405 study and its impact on treatment guidelines
-
1:27
dr. venook on distinguishing molecular features in crc
-
1:47
alan venook, md discusses development of immunotherapies for non msi-high crc patients
-
1:30
alan venook, md, discusses vemurafenib and the nccn guidelines for mcrc patients
-
3:08
alan venook, md, discusses uniqueness of msi-high/mismatch repair deficient crc patients
-
1:11
alan venook, md, tells us whether ctdna is a valid treatment response in crc
-
2:59
alan venook, md, provides opinions of the opra data in rectal cancer patients presented at asco20
-
11:54
paul's story
-
4:09
bowel cancer - my story
-
40:04
is immunotherapy an option for colorectal cancer patients? with dr. dung le
-
1:44
alan venook, md, considers how immunotherapy is being integrated into crc treatment algorithms
-
2:03
alan venook, md, explains the biological difference between left-sided and right-sided crc tumors
-
2:40
practical application of molecular testing in crc
-
1:39
alan venook, md, discusses next generation sequencing and mcrc treatment
-
2:56
current state of molecular testing for metastatic crc
-
1:13
alan venook, md, on the impact of dose escalation of regorafenib in mcrc patients
-
1:21
alan p. venook, md, provides his perspective on using tas-102 and regorafenib in crc patients
-
10:06
understanding tumor sidedness in colorectal cancer
-
2:16
alan venook, md, describes the potential practice changing results of the keynote-177 study
-
1:59
dr. venook on evolving treatment strategies in crc
-
1:01
alan venook, md talks about treatment strategies based on site of primary tumor in crc patients
Clip.africa.com - Privacy-policy